Evaluation of Totarol for Promoting Open Wound Healing in Dogs

This study investigates the susceptibility of common pathogens to totarol and assesses its clinical effectiveness in promoting wound healing in client-owned dogs with open wounds. Twenty-three client-owned dogs with open wounds were divided into two groups: (1) the treatment group (T-group) and (2) the control group (C-group). Clinical samples were collected from the wounds for the bacterial identification and determination of the minimum inhibitory concentrations (MICs) of totarol. In the T-group, wounds were treated with standard wound care together with the application at a dosage of 0.3 mL (two sprays) of commercial totarol product per 25 cm2 of the wound area. The C-group received only standard wound care. This in vitro study found that totarol exhibited antimicrobial activity against both standard pathogens and clinical wound pathogens. The MIC values of totarol dissolved in absolute ethyl alcohol were 4 µg/mL for Gram-positive pathogens and ranged from 256 to 512 µg/mL for Gram-negative pathogens. However, the MIC values of the commercial totarol product ranged from 512 to 1024 for both Gram-positive and Gram-negative pathogens. Clinically, the use of a commercial totarol product as an adjunctive therapy significantly improved wound healing, as indicated by a greater percentage of wound area reduction (p < 0.05). From day 2 to day 7 of the treatment, the percentage of wound area reduction differed significantly between the T-group and the C-group. At the end of the study, the average percentage of wound area reduction was 69.18% ± 18.12 and 41.50% ± 20.23 in the T-group and C-group, respectively. The finding of this study illustrates the antimicrobial properties of totarol and its product against prevalent wound pathogens. These results suggest the potential of totarol as an adjunctive option for canine wound care.

A balance of biocompatibility and antibacterial capability of 3D printed PEEK implants with natural totarol coating

OBJECTIVE

Polyetheretherketone (PEEK), a biomaterial with appropriate bone-like mechanical properties and excellent biocompatibility, is widely applied in cranio-maxillofacial and dental applications. However, the lack of antibacterial effect is an essential drawback of PEEK material and might lead to infection and osseointegration issues. This study aims to apply a natural antibacterial agent, totarol coating onto the 3D printed PEEK surface and find an optimized concentration with balanced cytocompatibility, osteogenesis, and antibacterial capability.

METHODS

In this study, a natural antibacterial agent, totarol, was applied as a coating to fused filament fabrication (FFF) 3D printed PEEK surfaces at a series of increasing concentrations (1 mg/ml, 5 mg/ml, 10 mg/ml, 15 mg/ml, and 20 mg/ml). The samples were then evaluated for cytocompatibility with L929 fibroblast and SAOS-2 osteoblast using live/dead staining and CCK-8 assay. The antibacterial capability was assessed by crystal violet staining, live/dead staining, and scanning electron microscopy (SEM) utilizing the oral primary colonizer S. gordonii and isolates of mixed oral bacteria in a stirring system simulating the oral environment. The appropriate safe working concentration for totarol coating is selected based on the results of the cytocompatibility and antibacterial test. Subsequently, the influence on osteogenic differentiation was evaluated by alkaline phosphatase (ALP) and alizarin red staining (ARS) analysis of pre-osteoblasts.

RESULTS

Our results showed that the optimal concentration of totarol solution for promising antibacterial coating was approximately 10 mg/ml. Such surfaces could play an excellent antibacterial role by inducing a contact-killing effect with an inhibitory effect against biofilm development without affecting the healing of soft and hard tissues around FFF 3D printed PEEK implants or abutments.

SIGNIFICANCE

This study indicates that the totarol coated PEEK has an improved antibacterial effect with excellent biocompatibility providing great clinical potential as an orthopedic/dental implant/abutment material.

Highly adhesive chitosan/poly(vinyl alcohol) hydrogels via the synergy of phytic acid and boric acid and their application as highly sensitive and widely linear strain sensors

In recent years, flexible strain sensors have attracted increasing interest, and accurate sensing and comfortable wearables are highly demanded. However, current flexible strain sensors fail to have wide linearity and high sensitivity simultaneously, and their adhesion is insufficient for convenient wear and precise motion monitoring. Herein, chitosan/poly(vinyl alcohol) hydrogels with phytic acid (PA) and boric acid (BA) as crosslinkers (CS/PVA-PA-BA hydrogels) were fabricated. The synergy of phytic acid and boric acid not only improved the mechanical properties of the obtained hydrogels (1070% of fracture strain and 0.83 MPa of fracture stress), but also provided them with outstandingly strong adhesion. Their adhesive strength was up to 527 kPa for a variety of materials, including glass, silica rubber, steel, polytetrafluoroethylene (PTFE), and skin. In addition, the hydrogel-based strain sensor demonstrated high sensitivity (gauge factor = 4.61), a wide linear strain range (up to 1000%, R2 = 0.996), fast response time (90 ms), and good stability. A flexible strain sensor with such high sensitivity and wide linear range simultaneously, to the best of our knowledge, has never been reported before. The development of CS/PVA-PA-BA hydrogels is expected to inspire a novel method for high-adhesive and high-sensing-performance wearable electronics.

Special Issue “Green Synthesis Processes of Polymers & Composites”

Undoubtedly, polymers and composites are the most important materials in the late XXth and early XXIst century [...]